What are the growth estimates for intravenous solutions markettill 2027?

The global intravenous solutions market is estimated to reach US$ 13,410.8 Million by 2027 . Read more

What are the key factors hampering growth of intravenous solutions market?

Increasing FDA recalls of IV products is one of the major factors that is expected to hamper growth of the market over the forecast period. Read more

What are the key factors driving growth of the intravenous solutions market?

Increasing approvals for intravenous solution injections from regulatory authoritiesis one of the major factors that is expected to propel growth of the market over the forecast period. Read more

What is the compound annual growth rate (CAGR) of the intravenous solutions market for next 8 years?

The global intravenous solutions market is estimated to exhibit a CAGR of 6.1% over the forecast period (2019-2027) . Read more

Intravenous Solutions Market Size, Trends, Shares, Insights and Forecast

Q: Which are the prominent intravenous solutions market players across the globe?

Major players operating in the global intravenous solutions market include Baxter International Inc, ICU Medical, Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited. Read more

Q: Which region is dominating the intravenous solutions market growth?

Among regions, Europe is expected to hold dominant position in the global intravenous solutions market over the forecast period. Read more

Summary Infographics Report Description Table Of Content Research Methodology Consult With Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Request Sample

Intravenous Solution Market – Insights

Intravenous solutions (IV) are administered in patients to provide sugar, salt and water directly into venous circulation. IV solutions and electrolytes are used for fluid resuscitation, routine maintenance, replacement, and redistribution. Nowadays, intravenous drugs, nutrition and mixed solutions have become an integral part of modern therapy. Adoption of inorganic growth strategies such as collaborations and acquisitions by key players in order to expand their portfolio of intravenous solutions is expected to drive growth of the global intravenous solutions market. For instance, in April 2015, Baxter International Inc. and France-based Laboratoire Aguettant SAS, entered into a licensing and distribution agreement for trace elements, which are essential micronutrients used in parenteral nutrition (PN) therapy.

The global intravenous solution market size was valued at US$ 8,372.0 million in 2019, and is expected to witness a CAGR of 6.1% over the forecast period (2019 – 2027).

Global Intravenous Solution Market Share (%) Analysis, By Solution, 2019

Source: Coherent Market Insights Analysis (2019)

Increasing Launches and Regulatory Approvals for Intravenous Solution Injection is expected to Drive Growth of the Global Intravenous Solution Market

Increasing approvals for intravenous solution injections from regulatory authorities is expected to drive the global intravenous solution market growth over the forecast period. For instance, in 2015, B. Braun Medical Inc, a subsidiary of B.Braun, operating in infusion therapy and pain management, announced the U.S. FDA approval for its 70% Dextrose for Injection in a 2L flexible container. 70% Dextrose for Injection is an intravenous solution indicated as a source of calories and fluid replenishment.

Launches of new intravenous solution injections for the treatment of various diseases such as dehydration, gastrointestinal diseases is expected to drive the intravenous solution market growth over the forecast period. For instance, in 2017, Fresenius Kabi USA, LLC, offers medicines and technologies for infusion, transfusion, and clinical nutrition, launched Vecuronium Bromide for Injection in the U.S. The drug is indicated for maintenance of neuromuscular blockade and paralysis.

Intravenous Solution Market - Restraints

Growth of the global intravenous solution market is expected to be hampered over the forecast period, owing to increasing FDA recalls of IV products. For instance, in August 2018, the U.S. FDA recalled Becton Dickinson & Company’s NEXIVA Closed IV Catheter System Dual Port 18GA 1.25 IN (BD Nexiva catheter) due to failure in the needle tip shield/safety mechanism.

Intravenous Solution Market- Regional Insights

On the basis of region, the global intravenous solution market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Europe is expected to hold a dominant position in the global intravenous solution market over the forecast period, owing to increasing launches of parenteral (intravenous) nutrition (PN) products. For instance, in 2016, Baxter International Inc, a global leader in PN therapy, launched NUMETA G13E 300 mL in Europe. NUMETA G13E is the only ready-to-use parenteral (intravenous) nutrition (PN) product for preterm infants (less than 37 weeks gestation age).

Among region, Asia Pacific is expected to foresee a rapid growth in the intravenous solution market, owing to increasing launches of technologically advanced intravenous solutions by key players. For instance, in June 2019, Eurolife Healthcare, a manufacturer and distributor of specialty infusion & pharmaceuticals, launched two intravenous IV products: Discport and Lifeport in the India drug market. The product is considered as smart intravenous infusion, which encompasses the latest technology that reduces the chances of any infection.

Global Intravenous Solution Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Source: Coherent Market Insights Analysis (2019)

Intravenous Solution Market - Competitive Landscape

Key players operating in the global intravenous solution market include Baxter International Inc, ICU Medical, Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited.

Report Description

Intravenous solutions are fluids, which are administrated to a patient directly into the venous circulation. These fluids are sterile, nonpyrogenic solutions used for fluid replenishment and caloric supply in single dose container for intravenous administration. Intravenous therapy is ideal for patients suffering from nutritional deficiency and dehydration. There are various types of intravenous solutions available in the market such as sodium chloride, lactated ringers, dextrose in water, and others.

Market Dynamics

Increasing prevalence of diarrhoea is expected to boost the global intravenous solution market growth over the forecast period. For instance, according to the World Health Organization (WHO), in May 2017, there were around 1.7 billion annual cases of childhood diarrheal disease across the globe.

Moreover, according to an article published in the Lancet Infectious Diseases, September 2018, diarrhoea was the third leading cause of disability-adjusted life year (DALYs) in 2016, which accounted for 74.4 million DALYs, globally. According to the same source, diarrhoea was the eighth leading cause of death, which accounted for 1,655,944 deaths in 2016.

Increasing cost of vitamin C intravenous therapy is expected to hinder the global intravenous solution market growth. For instance, in 2017, the China government took regulatory action of lowering vitamin C production owing to environmental concerns. This led to increase in prices of vitamin C by around 300% over the year. Furthermore, China produces 95% of the world’s vitamin C, which is used in food products, dietary supplements, and pharmaceuticals. The price of vitamin C was US$ 3.50 per kg in October 2016, which increased to US$ 12 per kg by September 2017, owing to environmental issues, which decreased China’s 30% of the vitamin C production.

Key features of the study:

This report provides in-depth analysis of the global intravenous solution market, market size (US$ Mn), and compound annual growth rate (CAGR %) over the forecast period (2019 – 2027), considering 2018 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global intravenous solution market based on the following parameters–company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Baxter International Inc. ICU Medical, Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global intravenous solution market report caters to various stakeholders in this industry, such as investors, product manufacturers, distributors, and suppliers for global intravenous solution market , research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

Global Intravenous Solution Market , By Solution Type:
- Saline
  - Normal Saline (0.9% NaCl)
  - Hypertonic Saline
- Dextran
- Lactated Ringer’s
- Amino Acid
- Vitamins & Minerals
- Heparin and Trace Elements
- Mixed Solutions
Global Intravenous Solution Market , By Bag Type:
- Large Volume Bags (greater than 250ml)
- Small Volume Bags (less than 250ml)
Global Intravenous Solution Market , By Application:
- Basic IV Solution
- Nutritional IV Solution
- Blood IV Solution
- Drug IV Solution
- Irrigation IV Solution
Global Intravenous Solution Market , By End-user:
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- Home Care Settings
Global Intravenous Solution Market , By Region:
- North America
  - By Country:
    - U.S.
    - Canada
  - By Solution Type :
    - Saline
      - Normal Saline (0.9% NaCl)
      - Hypertonic Saline
    - Dextran
    - Lactated Ringer’s
    - Amino Acid
    - Vitamins & Minerals
    - Heparin and Trace Elements
    - Mixed Solutions
  - By Bag Type:
    - Large Volume Bags (greater than 250ml)
    - Small Volume Bags (less than 250ml)
  - By Application:
    - Basic IV Solution
    - Nutritional IV Solution
    - Blood IV Solution
    - Drug IV Solution
    - Irrigation IV Solution
  - By End-user:
    - Hospitals
    - Clinics
    - Ambulatory Surgery Centers
    - Home Care Settings
- Europe
  - By Country:
    - U.K.
    - Germany
    - Italy
    - Spain
    - France
    - Russia
    - Rest of Europe
  - By Solution Type :
    - Saline
      - Normal Saline (0.9% NaCl)
      - Hypertonic Saline
    - Dextran
    - Lactated Ringer’s
    - Amino Acid
    - Vitamins & Minerals
    - Heparin and Trace Elements
    - Mixed Solutions
  - By Bag Type:
    - Large Volume Bags (greater than 250ml)
    - Small Volume Bags (less than 250ml)
  - By Application:
    - Basic IV Solution
    - Nutritional IV Solution
    - Blood IV Solution
    - Drug IV Solution
    - Irrigation IV Solution
  - By End-user:
    - Hospitals
    - Clinics
    - Ambulatory Surgery Centers
    - Home Care Settings
- Asia Pacific
  - By Country:
    - Australia
    - India
    - China
    - Japan
    - ASEAN
    - South Korea
    - Rest of Asia Pacific
  - By Solution Type :
    - Saline
      - Normal Saline (0.9% NaCl)
      - Hypertonic Saline
    - Dextran
    - Lactated Ringer’s
    - Amino Acid
    - Vitamins & Minerals
    - Heparin and Trace Elements
    - Mixed Solutions
  - By Bag Type:
    - Large Volume Bags (greater than 250ml)
    - Small Volume Bags (less than 250ml)
  - By Application:
    - Basic IV Solution
    - Nutritional IV Solution
    - Blood IV Solution
    - Drug IV Solution
    - Irrigation IV Solution
  - By End-user:
    - Hospitals
    - Clinics
    - Ambulatory Surgery Centers
    - Home Care Settings
- Latin America
  - By Country:
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
  - By Solution Type :
    - Saline
      - Normal Saline (0.9% NaCl)
      - Hypertonic Saline
    - Dextran
    - Lactated Ringer’s
    - Amino Acid
    - Vitamins & Minerals
    - Heparin and Trace Elements
    - Mixed Solutions
  - By Bag Type:
    - Large Volume Bags (greater than 250ml)
    - Small Volume Bags (less than 250ml)
  - By Application:
    - Basic IV Solution
    - Nutritional IV Solution
    - Blood IV Solution
    - Drug IV Solution
    - Irrigation IV Solution
  - By End-user:
    - Hospitals
    - Clinics
    - Ambulatory Surgery Centers
    - Home Care Settings
- Middle East
  - By Country/Region:
    - GCC
    - Israel
    - Rest of Middle East
  - By Solution Type :
    - Saline
      - Normal Saline (0.9% NaCl)
      - Hypertonic Saline
    - Dextran
    - Lactated Ringer’s
    - Amino Acid
    - Vitamins & Minerals
    - Heparin and Trace Elements
    - Mixed Solutions
  - By Bag Type:
    - Large Volume Bags (greater than 250ml)
    - Small Volume Bags (less than 250ml)
  - By Application:
    - Basic IV Solution
    - Nutritional IV Solution
    - Blood IV Solution
    - Drug IV Solution
    - Irrigation IV Solution
  - By End-user:
    - Hospitals
    - Clinics
    - Ambulatory Surgery Centers
    - Home Care Settings
- Africa
  - By Country/Region:
    - South Africa
    - Central Africa
    - North Africa
  - By Solution Type :
    - Saline
      - Normal Saline (0.9% NaCl)
      - Hypertonic Saline
    - Dextran
    - Lactated Ringer’s
    - Amino Acid
    - Vitamins & Minerals
    - Heparin and Trace Elements
    - Mixed Solutions
  - By Bag Type:
    - Large Volume Bags (greater than 250ml)
    - Small Volume Bags (less than 250ml)
  - By Application:
    - Basic IV Solution
    - Nutritional IV Solution
    - Blood IV Solution
    - Drug IV Solution
    - Irrigation IV Solution
  - By End-user:
    - Hospitals
    - Clinics
    - Ambulatory Surgery Centers
    - Home Care Settings
Company Profiles
- Baxter International Inc.*
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- ICU Medical, Inc.
- B. Braun Melsungen Ag
- Grifols, S.A.
- Fresenius Kabi USA, LLC
- Vifor Pharma Management Ltd.
- JW Life Science
- Amanta Healthcare
- Axa Parenterals Ltd.
- Salius Pharma Private Limited.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
Market Overview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Solution Type
  - Market Snippet, By Bag Type
  - Market Snippet, By Application
  - Market Snippet, By End User
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Industry Trend
- Impact Analysis
- Regulatory Scenario
- Key Developments
- Epidemiology
- Porter’s Five Forces Analysis
Global Intravenous Solution Market, By Solution Type, 2019 – 2027, (US$ Million)
- Introduction
  - Market Share Analysis, 2019 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Saline
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    - Normal Saline (0.9% NaCl)
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    - Hypertonic Saline
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Dextran
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Lactated Ringer’s
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Amino Acid
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Vitamins & Minerals
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Heparin and trace elements
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Mixed Solutions
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Global Intravenous Solution Market, By Bag Type 2019 – 2027, (US$ Million)
- Introduction
  - Market Share Analysis, 2019 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Large Volume Bags (greater than 250ml)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Small Volume Bags (less than 250ml)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Global Intravenous Solution Market, By Application 2019 – 2027, (US$ Million)
- Introduction
  - Market Share Analysis, 2019 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Basic IV Solution
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Nutritional IV Solution
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Blood IV Solution
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Drug IV Solution
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Irrigation IV Solution
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Global Intravenous Solution Market, By End User 2019 – 2027, (US$ Million)
- Introduction
  - Market Share Analysis, 2019 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Hospitals
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Clinics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Ambulatory Surgery Centers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Home care Settings
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Global Intravenous Solution Market, By Region, 2019 – 2027 (US$ Million)
- Introduction
  - Market Share Analysis, 2019 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Regional Trends
- North America
  - Market Size and Forecast, By Solution Type, 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Bag Type , 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Application , 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
    - U.S.
    - Canada
- Europe
  - Market Size and Forecast, By Solution Type, 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Bag Type , 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Application , 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Market Size and Forecast, By Solution Type, 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Bag Type , 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Application , 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
    - China
    - Japan
    - India
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Latin America
  - Market Size and Forecast, By Solution Type, 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Bag Type , 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Application , 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Africa
  - Market Size and Forecast, By Solution Type, 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Bag Type , 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Application , 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
    - North Africa
    - Central Africa
    - South Africa
- Middle East
  - Market Size and Forecast, By Solution Type, 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Bag Type , 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Application , 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
    - GCC Countries
    - Israel
    - Rest of Middle East
Competitive Landscape
- Company Profiles
  - Baxter International Inc.*
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - ICU Medical, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - B. Braun Melsungen Ag
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Grifols, S.A.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Fresenius Kabi USA, LLC
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Vifor Pharma Management Ltd.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - JW Life Science
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Amanta Healthcare
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Axa Parenterals Ltd.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Salius Pharma Private Limited.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
- Analyst Views
Global Intravenous Solution Market , By Region, 2019 – 2027 (US$ Million)
- References
- Research Methodology
- About Us and Sales Contact

*Browse 34 market data tables and 35 figures on "Intravenous Solution Market” - Global forecast to 2027”

Intravenous Solutions Market Analysis

PRESS RELEASE

Impact Analysis of Covid-19

Frequently Asked Questions

What are the growth estimates for intravenous solutions markettill 2027?

Which are the prominent intravenous solutions market players across the globe?

What are the key factors hampering growth of intravenous solutions market?

What are the key factors driving growth of the intravenous solutions market?

What is the compound annual growth rate (CAGR) of the intravenous solutions market for next 8 years?

Which region is dominating the intravenous solutions market growth?

Latest Reports

Ketorolac market analysis

Tigecycline products market analysis

Toxoplasmosis treatment drugs market analysis

Adrenoleukodystrophy drugs market analysis

Achondroplasia treatment market analysis

Existing Clientele

Contact Us

Menu

Quick Links

Newsletter

Connect With Us

Secure Payment By: